Skip to content

Bliska therapeutics

Active Risk: not assessed Limited partnershipfounded 2026active for less than a yearLovenjoelsestraat 8A, 3360 BierbeekKBO/BCE: BE 1039.617.987

Board

1 director, no change since July 2026
Manager (not named in the articles)
appointed by deed of 02-07-2026 term without a fixed end
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“De enige zaakvoerder vertegenwoordigt de vennootschap jegens derden en in rechte, zowel als eiser als verweerder.”
deed of 02-07-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Manager (not named in the articles)
Board
Mandates as a list
    • Manager (not named in the articles), appointed by deed of 02-07-2026, still in office

Control

Shareholders
,
This company
Bliska therapeutics

Articles of association

deed of 02-07-2026 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Profit allocationThe articles set how profit is distributed. A BV may only pay out after a balance-sheet and liquidity test.
Gewone meerderheid van stemmen, algemene vergadering
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December

Founders

Stated in the deed deed of 02-07-2026 ↗
  • gecommanditeerde vennoot
  • commanditaire vennoot

Next steps